23–24 January
London
Find us at booth 13
23–24 January 2024
Oxford PharmaGenesis is global, award-winning and independent. Our unique HealthScience approach uses proven behaviour change techniques to maximize the impact of your communications and to ensure they resonate with the target audience. Talk to us to learn how we can help you improve collaboration, innovation, and strategy and planning.
We want you to put your best foot forward in your publications journey. That's why we're giving away free pairs of Oxford PharmaGenesis-branded socks at ISMPP Europe!
Pick up your very own winter warmers at booth 13. And if you're looking to create impact, take your next step with Oxford PharmaGenesis.
Tuesday 23 January
13:25–14:10 and 14:15–15:00 GMT
Location: Cremant
Moderators: Amber Tear and Joana Osório from Oxford PharmaGenesis, in collaboration with members of Open Pharma
Open access has become the dominant model in scientific publishing; however, as its increased adoption transforms the publishing landscape, the sustainability and equity of the traditional open access business model are being questioned, and alternative models are emerging.
Join this roundtable at ISMPP Europe to discover how the conversation around open access is evolving and to explore publications options that maximize the impact of your content.
Amber, Joana and other valued members of Open Pharma will moderate a discussion on traditional and emerging open access models, copyright licenses and content ownership. You will feel better-equipped to choose between different publishing options and to advise publications and compliance colleagues about the implications of selecting each option. The roundtable group will also evaluate whether new ideas that are gaining traction in academia could be used by the pharmaceutical industry or specific companies.
Tuesday 23 January
13:25–14:10 and 14:15–15:00 GMT
Location: Cremant
Moderators: Kim Johnson and Vicky Sanders from Oxford PharmaGenesis, in collaboration with members of Open Pharma
Open sharing of research data is becoming increasingly mandated, recommended and expected by regulators, publishers and the public. Responsible data sharing increases the efficiency and reproducibility of the research process, reduces waste and promotes trust in the pharmaceutical industry, but data breaches have the opposite effect.
Most biomedical research journals now have data sharing requirements for publication.
Join this roundtable at ISMPP Europe to share your experiences with implementing journal data sharing policies when submitting industry-sponsored research for publication.
Kim, Vicky and other valued members of Open Pharma will discuss case studies of specific challenges, their outcomes and impact, and will explore how to minimize these challenges while promoting and supporting ethical and responsible data sharing.
Poster 8
Poster 11
Poster 19
Poster 21
Guided poster tour
Tuesday 23 January
14:15–15:00 GMT
St Julien Suite
Poster 26
Poster 30
Guided poster tour
Tuesday 23 January
14:15–15:00 GMT
St Julien Suite
From infographics to plain language summaries, publications enrichments can increase your reach, enhance engagement and comprehension, and drive real-world impact.
Communications Consultant
I have been a Medical Writer at Oxford PharmaGenesis for over 6 years and I recently joined the Open Pharma team. At ISMPP Europe 2024, I will be helping to facilitate one of the roundtables we are hosting, and I can’t wait to be involved in the discussions!
Director of Innovation
I lead innovation initiatives across Oxford PharmaGenesis, supporting our clients and delivery teams in finding creative solutions to new and existing challenges. I am also honoured to be the Chair elect of the ISMPP Board of Trustees. ISMPP Europe 2024 will be fizzing with new ideas and innovations around the use of AI, and I’ll be looking forward to discussing some of the exciting work being conducted by Oxford PharmaGenesis in this space.
Communications Director
I’m really looking forward to connecting with colleagues and clients at ISMPP Europe 2024 to hear about the latest advances in publications, and particularly the role and impact of patient engagement!
Chief Operating Officer
ISMPP meetings are a great combination of a reunion of old friends and an opportunity to establish new connections, and such relationships are particularly important in these times of change in our sector. Excellent communication of science and value remains an imperative, and I’m very much looking forward to conversations around how we can embrace new technologies and new models of engagement to deliver together!
Scientific Director
I’m the Scientific Director in the AI and Data Science Team here at Oxford PharmaGenesis. The recent progress in generative AI has shaken up the world of medical writing, and its impact continues to reverberate through the pharmaceutical industry. I’m really looking forward to hearing about how fellow ISMPP members are considering its potential benefits and pitfalls.
Senior Account Manager
Working as a Senior Account Manager in the Open Pharma project, ISMPP Europe is an exciting time for me to engage in the hot topics of discussion around open science in pharma, as well to cast an eye to the future so that we can stay innovative and forward-focused.
Communications Consultant
As the Project Lead of Open Pharma, I’m looking forward to discussing progress and opportunities in open science with the ISMPP community, including open access, plain language summaries, data sharing, authorship, discoverability, AI and patient engagement. I’m also looking forward to connecting with companies interested in becoming members of Open Pharma.
Communications Director
As someone who cares passionately about excellence in publications and evidence communication, ISMPP is always a highlight of the year for me. It has particular significance this year, as I was privileged to participate in the organizing committee. I can’t wait to see how everything has come together and have some great discussions with clients and colleagues about the innovations that will help us evolve our communications in the best way possible!
Associate Medical Writer
I have been an Associate Medical Writer at Oxford PharmaGenesis for 1 year and I am looking forward to attending my first ISMPP event. I am excited to join my co-authors to share our work on publication metrics and engaging with fellow attendees on innovative ways to enhance publication planning.
Senior Medical Writer
As a Senior Medical Writer in our Patient Engagement Team, I’m looking forward to engaging with and learning from all of the excellent patient-centric research and content that always emerges from ISMPP.
Chief Executive Officer
In our hybrid world, ISMPP is a unique opportunity to reconnect with clients, colleagues and other contacts involved in communicating groundbreaking science to the wider world. I particularly enjoy the poster presentations showcasing best practice and advancing our profession. I am really excited that the finalized ACCORD reporting guideline for consensus methods in biomedicine will be presented during the conference, which will be a great venue for celebrating with my co-authors!
Senior Medical Writer
I've been working at Oxford PharmaGenesis for almost 4 years now, predominantly focusing on real-world evidence publications. I'm looking forward to meeting clients face to face, as well as getting a much clearer picture of the current landscape of publications!
To speak to one of our team about how we can support you, please fill in the contact form below.
